explore -WSS

explore

author：entertainment 2025-10-01 22:58:19 - browse：14

Dr. Peter Bach — Peter Bach, shown at the 2019 STAT summit, is now chief medical officer of Delfi. Emilie Pickering for STAT

Delfi Diagnostics, a well-funded startup in the burgeoning field of creating blood tests to detect cancer, said on Monday that it is launching a new test, FirstLook Lung, to try to identify people who could most benefit from lung cancer screening.

The approach represents a new one in the field of liquid biopsy, in which DNA fragments in blood are used to detect or learn about tumors. Grail, another company developing a blood test for cancer screening, has insisted that its product would be best used to detect multiple cancers at once. Other companies, including Exact Sciences and Freenome, are developing tests that would focus on detecting colorectal cancer. But Delfi appears to be the first to focus first on lung cancer, the leading cause of cancer death.

Delfi’s executives, in an interview with STAT, were clear that they view the initial launch as an opportunity to gather information, and not a real commercial coming out. The test will likely become available in limited ways with specific partners and will not initially be covered by insurance. Delfi declined to reveal a specific price, but said that its early access customers, which it is not yet disclosing, will be able to use FirstLook Lung for several hundred dollars. Such a rollout does not require approval from the Food and Drug Administration, which Delfi does not have.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： What AstraZeneca

WSS

5 wounded, 2 critically, in Michigan shopping center shooting

A pollution tax on older cars can be extended to London's suburbs after a British court ruling

Better Therapeutics data on benefit with GLP

Better Therapeutics data on benefit with GLP

What's changing in Medicare's open enrollment this year?

Life sciences deals on track to hit lowest point since 2017

explore

explore

focus

Supreme Court strikes down use of affirmative action

How doctors and nurses shape Google's AI

In age of alternative facts, a scholarly course on calling out crap

Japan raises alarm over China's military, Russia ties and Taiwan tensions in new defense paper

In Memoriam: Notable people who died in 2023

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

State Dept. review finds Biden bears some blame for Afghanistan failures

How clinical AI models' predictive power can degrade over time

Anesthesiologist group: stop taking Ozempic before surgery

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

hotspot

European regulators consider appeal over Amylyx ALS drug

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

House GOP plan to stem drug shortages differs from Democrats’

5 wounded, 2 critically, in Michigan shopping center shooting

Life sciences deals on track to hit lowest point since 2017

Doctors in states that ban abortion can still help patients

Wikipedia

knowledge

focus

Wikipedia